Atlas Trials

Effect of Propofol and Desflurane on Nucleic Acid of Liver Circulating Tumor

Clinical trial NCT05502458 · COMPLETED

Trial details

NCT number
NCT05502458
Sponsor
Zhejiang Cancer Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatocellular CarcinomaDesflurane Adverse ReactionPropofol Adverse ReactionCirculating Tumor Cells
Start date
2020-12-01
Primary completion
2022-08-08
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.